NasdaqCM - Delayed Quote USD

IceCure Medical Ltd (ICCM)

Compare
1.0700 +0.1300 (+13.83%)
At close: December 13 at 4:00:02 PM EST
1.0701 +0.00 (+0.01%)
After hours: December 13 at 7:56:47 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,671.0000
3,229.0000
3,085.0000
4,138.0000
3,868.0000
Cost of Revenue
2,068.0000
1,929.0000
1,640.0000
1,943.0000
1,424.0000
Gross Profit
1,603.0000
1,300.0000
1,445.0000
2,195.0000
2,444.0000
Operating Expense
16,189.0000
16,876.0000
18,184.0000
11,919.0000
6,586.0000
Operating Income
-14,586.0000
-15,576.0000
-16,739.0000
-9,724.0000
-4,142.0000
Net Non Operating Interest Income Expense
752.0000
924.0000
-239.0000
-171.0000
412.0000
Other Income Expense
--
--
--
--
-55.0450
Pretax Income
-13,834.0000
-14,652.0000
-16,978.0000
-9,895.0000
-3,730.0000
Net Income Common Stockholders
-13,834.0000
-14,652.0000
-16,978.0000
-9,895.0000
-3,730.0000
Diluted NI Available to Com Stockholders
-13,834.0000
-14,652.0000
-16,978.0000
-9,895.0000
-3,730.0000
Basic EPS
-0.28
-0.32
-0.46
-0.35
-0.22
Diluted EPS
-0.28
-0.32
-0.46
-0.35
-0.22
Basic Average Shares
48,293.8150
45,638.0300
37,016.6310
28,548.6760
17,128.9030
Diluted Average Shares
48,293.8150
45,638.0300
37,016.6310
28,548.6760
17,128.9030
Total Operating Income as Reported
-14,586.0000
-15,576.0000
-16,739.0000
-9,724.0000
-4,142.0000
Total Expenses
18,257.0000
18,805.0000
19,824.0000
13,862.0000
8,010.0000
Net Income from Continuing & Discontinued Operation
-13,834.0000
-14,652.0000
-16,978.0000
-9,895.0000
-3,730.0000
Normalized Income
-13,834.0000
-14,652.0000
-16,978.0000
-9,895.0000
-3,730.0000
Interest Income
--
--
--
--
4.0429
Interest Expense
--
--
--
--
31.7209
Net Interest Income
752.0000
924.0000
-239.0000
-171.0000
412.0000
EBIT
-14,586.0000
-15,576.0000
-16,739.0000
-9,724.0000
-4,142.0000
EBITDA
-14,253.0000
-15,253.0000
-16,491.0000
-9,597.0000
-4,079.0000
Reconciled Cost of Revenue
2,068.0000
1,929.0000
1,640.0000
1,943.0000
1,424.0000
Reconciled Depreciation
333.0000
323.0000
248.0000
127.0000
63.0000
Net Income from Continuing Operation Net Minority Interest
-13,834.0000
-14,652.0000
-16,978.0000
-9,895.0000
-3,730.0000
Total Unusual Items Excluding Goodwill
--
--
--
--
-55.0450
Total Unusual Items
--
--
--
--
-55.0450
Normalized EBITDA
-14,253.0000
-15,253.0000
-16,491.0000
-9,597.0000
-4,079.0000
12/31/2020 - 8/26/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BWAY BrainsWay Ltd.
9.42
-3.19%
 
MDAI Spectral AI, Inc.
1.8000
-10.89%
 
TNON Tenon Medical, Inc.
1.9600
-4.39%
 
BMRA Biomerica, Inc.
0.3138
+8.24%
 
XYLO Xylo Technologies Ltd.
3.6000
-2.17%
 
SINT Sintx Technologies, Inc.
3.1000
-4.62%
 
TRIB Trinity Biotech plc
0.9050
+0.67%
 
AEMD Aethlon Medical, Inc.
0.3586
-1.97%
 
NAOV NanoVibronix, Inc.
0.6148
+0.79%
 
NUWE Nuwellis, Inc.
1.1800
-2.48%